Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China’s Essential Drug List Expected In June

This article was originally published in PharmAsia News

Executive Summary

At a recent national pharmacist conference in Beijing, high-level executives and experts from China's government organizations such as the Ministry of Health, State FDA and National People's Congress Finance and Economy Committee gathered to discuss the healthcare reform. The spotlight was on the long-awaited essential drug list (PharmAsia News, May 2007, 2009), which authorities indicated would likely be out by the end of June. A large reduction in the number of TCM entries was confirmed. Also, healthcare institutions will need to prescribe essential drugs by percentage of revenue rather than by drug types. Relevant supplementary documents will be issued progressively for the list, including implementation opinions and administration regulations. Analysts believe that in the short term, the essential drug market will be concentrated at grassroots-level and rural medical organizations. (Click here for more - Chinese Language)

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts